Our medical providers can prescribe Zepbound (tirzepatide) in a pen to patients. Shipped directly to you, it’s the most convenient way to start your weight loss journey.
- A new way to access FDA-approved GLP-1s. See safety info below.
- The fastest way to lose weight.
- Targets two hormone receptors to curb hunger with less nausea.
What is Zepbound?
Zepbound uses the same active ingredient (tirzepatide) as Mounjaro®. It’s a dual-action GLP-1/GIP-receptor agonist that is approved by the FDA for people with obesity or overweight, plus a weight-related condition, along with diet and exercise changes.
How is Zepbound different from Ozempic® or Wegovy®?
Zepbound and Wegovy are approved by the FDA for weight loss, while Ozempic is approved for the treatment of type 2 diabetes, but can be prescribed off-label for weight loss, if appropriate.
The main difference between these medications is the active ingredient. Ozempic and Wegovy use semaglutide, while Zepbound uses tirzepatide. Tirzepatide is a dual-action GLP-1 and GIP receptor agonist, meaning it works by activating two receptors to curb nausea and regulate metabolism, helping you feel full faster and for longer. In comparison, semaglutide only activates the GLP-1 receptor.
Safety info: GLP-1 medications are used to treat obesity or overweight (with weight-related problems), along with diet and exercise. They may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. See more serious warnings & safety info.